Malik, Z., Di Lorenzo, G., Pichler, A., Hitier, S., Ecstein-Fraisse, E., Carles Galceran, J., & De Giorgi, U. (2020). Effect of Baseline Characteristics on Cabazitaxel Treatment Duration in Patients with Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the Compassionate Use/Expanded Access Programs and CAPRISTANA Registry.
Citación estilo ChicagoMalik, Zafar, Giuseppe Di Lorenzo, Angelika Pichler, Simon Hitier, Evelyne Ecstein-Fraisse, Joan Carles Galceran, y Ugo De Giorgi. Effect of Baseline Characteristics On Cabazitaxel Treatment Duration in Patients With Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the Compassionate Use/Expanded Access Programs and CAPRISTANA Registry. 2020.
Cita MLAMalik, Zafar, et al. Effect of Baseline Characteristics On Cabazitaxel Treatment Duration in Patients With Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the Compassionate Use/Expanded Access Programs and CAPRISTANA Registry. 2020.